Sort
4,870 grants matching “glp 1”
cGMP manufacturing of PBI-220, a broad spectrum immunoadhesin therapeutic against
$1,578,528Lloyd M Yu · Planet Biotechnology, Inc. · R01 · FY2011 · AI
SmartInsulin ADME and IND-enabling Preclinical Studies
$1,578,278Todd C Zion · Smartcells, Inc. · R44 · FY2009 · DK
Development of a novel, regenerative therapy to reverse synapse loss in Alzheimer's Disease
$1,574,900Peter W Vanderklish · Spinogenix, Inc. · R44 · FY2024 · AG
Bacteriophage virus-like particle vaccines for fentanyl and heroin overdose
$1,572,708Bryce C Chackerian · University Of New Mexico Health Scis Ctr · UG3 · FY2021 · DA
New Generation of Mitochondrial Uncouplers for the Treatment of Metabolic DIsorders
$1,571,137Simon Vu · Equator Therapeutics, Inc. · R44 · FY2025 · DK
New Generation of Mitochondrial Uncouplers for the Treatment of Metabolic DIsorders
$1,571,137Simon Vu · Equator Therapeutics, Inc. · R44 · FY2024 · DK
Innovative 3D Printed Intravaginal Ring AnelleO-PRO, the first Single Administration of Progesterone for Infertility
$1,570,185Rima Janusziewicz · Anelleo, Inc. · R44 · FY2023 · HD
Biomarker Rich Clinical Trial of an Innovative Antibody Antagonist of TNFR2 in Non-Hodgkin Lymphoma Featuring Cutaneous T Cell Lymphoma (CTCL).
$1,565,481David G Brooks · Boston Immune Technologies And Therapeutics, Inc. · R44 · FY2024 · CA
Treatment of pulmonary fibrosis with inhibitors of integrin alphavbeta1.
$1,555,009Dean Sheppard · University Of California, San Francisco · UH3 · FY2017 · HL
RP1: rVSV Vectored Vaccine to Treat Ebola and Marburg Infection
$1,554,735John H Eldridge · University Of Texas Med Br Galveston · U19 · FY2014 · AI
Clinical and Informatics Research on Large Clinical Databases
$1,554,491Clement McDonald · National Library Of Medicine · ZIA · FY2021 · LM
Physiology, Psychology, and Genetics of Obesity
$1,553,253Jack A. Yanovski · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2022 · HD
National Islet Cell Consortium Coordinating Center
$1,550,230Joyce Carol Niland · Beckman Research Institute/City Of Hope · U42 · FY2008 · RR
RNAi Therapy for Spinocerebellar Ataxia Type 1
$1,548,744Beverly L Davidson · Children'S Hosp Of Philadelphia · UH3 · FY2019 · NS
Developing autologous iPSC-RPE based IND for AMD patients
$1,548,029Kapil Bharti · National Eye Institute · ZIA · FY2025 · EY
GMP Production and Extended Toxicology of an Oral Formulation Drug for Alzheimer's Disease
$1,547,324D. Martin Watterson · Northwestern University At Chicago · U01 · FY2023 · AG
GMP Production and Extended Toxicology of an Oral Formulation Drug for Alzheimer's Disease
$1,546,977D. Martin Watterson · Northwestern University At Chicago · U01 · FY2022 · AG
SmartInsulin Stability, Process Development, Assay Validation and GMP Manufacturi
$1,546,698Todd C Zion · Smartcells, Inc. · R44 · FY2008 · DK
GMP Production and Extended Toxicology of an Oral Formulation Drug for Alzheimer's Disease
$1,546,636D. Martin Watterson · Northwestern University At Chicago · U01 · FY2024 · AG
Inhaled GM-CSF Therapy of Autoimmune Pulmonary Alveolar Proteinosis
$1,546,330Sharie Haugabook · National Center For Advancing Translational Sciences · ZIA · FY2019 · TR
Improved Dosing and Refinement of a Cardiac Targeted Gene Therapy in a Swine Infarct Model
$1,545,537Sam Teichman · Beat Biotherapeutics Corporation · R44 · FY2016 · HL
Influenza vaccination using a microneedle patch
$1,542,519Mark R Prausnitz · Georgia Institute Of Technology · U01 · FY2010 · EB
A potassium-ATP channel opener for prevention of contrast-induced nephropathy
$1,527,261Andrew L Salzman · Radikal Therapeutics, Inc. · R44 · FY2014 · DK
Preclinical development of a precision therapy for a monogenic mental health disorder
$1,524,504Courtney A Miller · University Of Florida · U01 · FY2024 · MH
SBIR Phase II: Novel Hyaluronan Enhanced Polymeric Trans-Catheter Aortic Valve
$1,518,670Todd Charles Tomba · Youngheartvalve Llc · R44 · FY2025 · HL